Ask AI

ClinicalThought

Share

Program Content

Activities

  • Adv <i>EGFR+</i> NSCLC in 2021
    What Everyone Should Know About Management of Advanced EGFR-Mutated Non-Small-Cell Lung Cancer in 2021
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 08, 2021

  • Adv <i>EGFR</i>+ NSCLC: EU/US Perspectives
    Regional Perspectives on Current Management of Advanced EGFR-Mutated Non-Small-Cell Lung Cancer
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 20, 2021

  • Liquid Biopsy in <i>EGFR+</i> NSCLC
    My Thoughts on the Evolving Role of Liquid Biopsies in the Treatment of EGFR Mutation–Positive Advanced NSCLC
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 01, 2021

  • Barriers to Osimertinib
    First-line Osimertinib for EGFR-Mutated Advanced NSCLC: Barriers to Access and Future Directions
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 29, 2021

Provided by

ProCE Banner

Supporters

AstraZeneca